MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Can Simple Home Based Exercises Reduce the Fear of Falling in Parkinson Disorders?

    R. Neupane, P. Kukkle (Bangalore, India)

    Objective: To examine the potential benefit of a simple home-based gait and balance training on fear of fall in patients with Parkinson’s (PwP). Background: PwP…
  • 2024 International Congress

    Speaking Out for Speech Therapy: Referral Patterns and Disparities in PD

    R. Nitschelm, K. Smith (Worcester, USA)

    Objective: Determine the referral rates and associated disparities in referral to Speech Language Pathology (SLP) in a large healthcare system in Central Massachusetts. Background: People…
  • 2024 International Congress

    Parkinson’s Disease Clinical Subtypes Differ in Health-Related QOL

    E. Carr, T. Cash, C. Lessov-Schlaggar, H. Hwang, A. Eid, P. Kotzbauer, J. Perlmutter, M. Campbell (St. Louis, USA)

    Objective: To determine whether clinical subtypes of Parkinson disease (PD) differ in health-related quality of life (QOL). Background: Health-related QOL varies for individuals with PD.…
  • 2024 International Congress

    Transforming Parkinson’s Care in Africa: Establishing a Global Virtual Support Group for Africans Impacted by Parkinson’s Disease

    E. Bruce, M. Cham, T. Park, N. Fothergill-Misbah (Sogakope, Ghana)

    Objective: To establish a monthly Global Virtual Support Group for Africans impacted by Parkinson's disease as part of the Transforming Parkinson’s Care in Africa (TraPCAf)…
  • 2024 International Congress

    Combining MDS-UPDRS Parts 1 and 2: using the patient’s voice

    C. Goetz, H. Zou, G. Stebbins, A. Schrag, T. Mestre, S. Luo (Chicago, USA)

    Objective: To test whether the patient-derived MDS-UPDRS Parts assessing non-motor (Part 1) and motor (Part 2) functional impact of PD can be summed to render…
  • 2024 International Congress

    Safety and Tolerability of Ecopipam in Tourette Syndrome (TS) with Psychiatric Comorbidities.

    D. Gilbert, S. Atkinson, G. Karkanias, R. Munschauer, S. Wanaski, T. Cunniff (Cincinnati, USA)

    Objective: Evaluate the effect of ecopipam in children and adolescents with TS on measures of attention deficit disorder (ADHD), anxiety disorders (ANX), obsessive-compulsive disorder (OCD)…
  • 2024 International Congress

    Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study

    H. Sarva, M. Tagliati, W. Poewe, F. Stocchi, O. Rascol, T. Yardeni, N. Lopes, J. Pereira, A. Espay (New York, USA)

    Objective: Evaluate quality of life (QoL) data from the Phase 3 randomized, active-controlled BouNDless study. Background: Pivotal data from the BouNDless study (NCT04006210) showed that…
  • 2024 International Congress

    Gait Digital Outcomes Exploration from Continuous Real-World Recordings in Parkinson’s Disease

    M. Michaud, G. Parinello, E. Kluczka, C. Cluzeau, M-L. Brechemier, F. Bompaire, C. Tafani, M. Sallansonnet-Froment, T. Gidaro, L. Oudre, D. Ricard (Gif-Sur-Yvette, France)

    Objective: To measure how people with Parkinson's disease (PD) feel, function, and survive, derived from continuous recordings with a wearable ankle inertial device in a real-world…
  • 2024 International Congress

    Effect of Opicapone and Levodopa on Daily Motor Patterns in Parkinson’s Disease Patients with Early Motor Fluctuations: Findings from the Korean ADOPTION Study

    J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)

    Objective: To evaluate the effect of opicapone (OPC) 50 mg versus an additional 100 mg dose of levodopa (L-DOPA) on ON-/OFF-daily patterns in patients with…
  • 2024 International Congress

    A matching-adjusted indirect comparison of efficacy and safety for safinamide versus rasagiline as adjunctive treatment to levodopa in Chinese patients with Parkinson’s disease

    Y. Tan, Q. Wei, P. Xu, E. Tao, L. Wang, C. Cattaneo, H. Shang, S. Chen (Shanghai, China)

    Objective: To compare  efficacy and safety of safinamide and rasagiline as adjunctive treatment to levodopa in Chinese patients with Parkinson’s disease (PD) by matching-adjusted indirect…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley